Hadassah

Hadassah Physician/Researchers Identify Defective Gene and Halt Paralysis of Babies’ Limbs and Vocal Cords

Friday, Dec 21 2012

Identifying the defective gene that has caused neuropathy in children of North African descent, physician/researchers at the Hadassah Medical Center have employed an experimental drug to prevent permanent paralysis of both muscle and vocal cords in four children.

The rare genetic disease, whereby erosion of the myelin (the coating on the nerves) impedes the nerves’ ability to transmit signals from the spinal cord to the muscles of the limbs, is referred to as “The Curse” by the susceptible population. Seemingly healthy babies developed paralysis after contracting a viral infection. Prof. Orly ElPeleg, head of the Department of Genetics and Metabolic Diseases, and Prof. Dror Mevorach, head of Internal Medicine B and the Center of Rheumatology Research at Hadassah Hospital-Ein Kerem, report that since all the children were of North African origin and one of the families had two children with the condition, they were able to identify the defective gene using advanced technology.

Read more in the Jerusalem Post here>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

A Birthday Party in Hadassah’s PICU: Helping a Four-Year-Old Recover

Yehoshua "Shuki" Pepper was crossing a Jerusalem street with an older sibling when a car ran him over. He was rushed to Hadassah Hospital Ein Kerem's Pediatric Intensive Care Unit in fair condition, but he wasn't speaking and subsequent MRIs of his head injury were worrisome.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›
alt_text

Monday, Nov 14 2016

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Granalix BioTechnologies, whose founder and Chief Executive Officer is Hadassah Medical Organization Experimental Neurologist Prof. Ruth Gabizon, has launched a food supplement containing pomegranate oil that has proven to protect against neurodegenerative diseases in pre-clinical models.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More